Veradermics Incorporated MANE
—
116.57
0.85
0.73%
as of 25 Sep
- Market cap
- $5.0B
- P/E
- 0.0×
Follow MANE
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | |
|---|---|---|
Current Ratio |
16.66 | 11.77 |
Net Debt/EBITDA |
1.96 | 1.98 |
Debt/Assets |
0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 |
Asset Turnover |
0.00 | — |
Operating CF/Net income |
0.86 | 0.87 |
Capex/Depreciation |
0.00 | — |
Interest Coverage |
0.00 | 0.00 |
| 98.38% | 0.00% | |
| (80.11%) | 0.00% | |
ROIC |
0.00% | 0.00% |
Return on Tangible Assets |
(58.15%) | (53.73%) |
Research and Development Expense of Revenue |
0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% |
Free Cash Flow per Share |
(96.14) | (32.14) |
Cash per Share |
190.42 | 72.03 |
Shareholders Equity per Share |
(162.43) | (65.78) |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
(162.43) | (65.78) |
Free Cash Flow |
(71.63) | (23.69) |
Working Capital |
143.34 | 50.82 |
Capital Expenditures |
(0.02) | — |
Net Current Asset Value |
(121.14) | (48.48) |
| Other line items | ||
Quick Ratio |
15.50 | 11.25 |
Depreciation/Fixed assets |
0.00 | — |
Cash ROIC |
(343.55%) | (514.51%) |
Accounts Payable Turnover |
0.00 | — |
Average Days of Payables |
0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 |
Operating CF per Share |
(96.11) | (32.14) |
Capex per Share |
(0.03) | 0.00 |
Average Payables |
2.19 | — |
Average Assets |
104.08 | — |
Average Common Equity |
(84.75) | — |
Capex to Sales |
0.00 | — |
Net Profit Margin |
0.00% | 0.00% |
Columns are period end dates